2023 has been the year of headlines, hype and anxiety about generative artificial intelligence and its capabilities, and biopharma is among the many business sectors trying to figure out how the technology could boost productivity.
Interest in AI was evident at the Jefferies healthcare conference in London last week, where attendees crammed into the room...